NHS England accused of interference over hepatitis C drug
NHS England officials have been accused of trying to interfere with the appraisal of a new drug for hepatitis C sufferers due to their concerns overs its cost.
NHS England officials have been accused of trying to interfere with the appraisal of a new drug for hepatitis C sufferers due to their concerns overs its cost.
If this winter has identified anything it is that the health and social care system is not working together as well as it should. Indeed, some less kindly souls might say it’s barely working at all.
It’s a drug that cures hepatitis C in 90 per cent of cases – but a 12-week course costs £35,000. And now NHS England is worried that it’s too expensive.
Wrists have been slapped today by the National Institute for Health and Care Excellence – otherwise known as NICE.
The Conservative Party claims it can pay for all cancer drugs on the NHS from the money it “saves” by not implementing the National Insurance rise.
Sarah Smith blogs that debate over breast cancer treatment in the US is being driven by arguments over whether women are being given so much treatment that it’s actually bad for them.